{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:25:15Z","timestamp":1783527915937,"version":"3.55.0"},"reference-count":52,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pulmonary arterial hypertension (PAH) is an incurable disease characterized by disordered and dysfunctional angiogenesis leading to small-vessel loss and an obliterative vasculopathy. The pathogenesis of PAH is not fully understood, but multiple studies have demonstrated links between elevated angiostatic factors, disease severity, and adverse clinical outcomes. ES (endostatin), one such circulating angiostatic peptide, is the cleavage product of the proteoglycan COL18A1 (collagen \u03b11[XVIII] chain). Elevated serum ES is associated with increased mortality and disease severity in PAH. A nonsynonymous variant of ES (aspartic acid\u2013to-asparagine substitution at amino acid 104; p.D104N) is associated with differences in PAH survival. Although COL18A1\/ES expression is markedly increased in remodeled pulmonary vessels in PAH, the impact of ES on pulmonary endothelial cell (PEC) biology and molecular contributions to PAH severity remain undetermined. In the present study, we characterized the effects of exogenous ES on human PEC biology and signaling. We demonstrated that ES inhibits PEC migration, proliferation, and cell survival, with significant differences between human variants, indicating that they are functional genetic variants. ES promotes proteasome-mediated degradation of the transcriptional repressor ID1, increasing expression and release of TSP-1 (thrombospondin 1). ES inhibits PEC migration via an ID1\/TSP-1\/CD36-dependent pathway, in contrast to proliferation and apoptosis, which require both CD36 and CD47. Collectively, the data implicate ES as a novel negative regulator of ID1 and an upstream propagator of an angiostatic signal cascade converging on CD36 and CD47, providing insight into the cellular and molecular effects of a functional genetic variant linked to altered outcomes in PAH.<\/jats:p>","DOI":"10.1165\/rcmb.2019-0056oc","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T14:03:06Z","timestamp":1578664986000},"page":"524-534","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":28,"title":["Functional Impact of Human Genetic Variants of\n                    <i>COL18A1<\/i>\n                    \/Endostatin on Pulmonary Endothelium"],"prefix":"10.1093","volume":"62","author":[{"given":"Alice M.","family":"Goyanes","sequence":"first","affiliation":[{"name":"Respiratory Institute, Cleveland Clinic, Cleveland, Ohio; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aigul","family":"Moldobaeva","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mery","family":"Marimoutou","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidenys C.","family":"Varela","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura F.","family":"Johnston","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena M.","family":"Aladdin","sequence":"additional","affiliation":[{"name":"Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L.","family":"Peloquin","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo S.","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendra","family":"Damarla","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Suresh","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Kolb","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-1557","authenticated-orcid":false,"given":"Rachel L.","family":"Damico","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, Department of Medicine, and"},{"name":"Department of Environmental Health Sciences, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"2026021100415901400_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"2026021100415901400_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1465-9921-10-95","article-title":"Endothelial cells and pulmonary arterial hypertension: apoptosis, proliferation, interaction and transdifferentiation","volume":"10","author":"Sakao","year":"2009","journal-title":"Respir Res"},{"key":"2026021100415901400_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1096\/fj.00-0343com","article-title":"Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension","volume":"15","author":"Taraseviciene-Stewart","year":"2001","journal-title":"FASEB J"},{"key":"2026021100415901400_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2009.12.006","article-title":"Role of apoptosis in pulmonary hypertension: from experimental models to clinical trials","volume":"126","author":"Jurasz","year":"2010","journal-title":"Pharmacol Ther"},{"key":"2026021100415901400_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-\u03b2 receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"key":"2026021100415901400_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1465-9921-12-84","article-title":"Physiologic and molecular consequences of endothelial Bmpr2 mutation","volume":"12","author":"Majka","year":"2011","journal-title":"Respir Res"},{"key":"2026021100415901400_bib7","doi-asserted-by":"crossref","first-page":"L548","DOI":"10.1152\/ajplung.00428.2006","article-title":"Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension","volume":"293","author":"Masri","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021100415901400_bib8","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1161\/CIRCULATIONAHA.109.927681","article-title":"Formation of plexiform lesions in experimental severe pulmonary arterial hypertension","volume":"121","author":"Abe","year":"2010","journal-title":"Circulation"},{"key":"2026021100415901400_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/002215540305100303","article-title":"The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo","volume":"51","author":"Miosge","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"2026021100415901400_bib10","doi-asserted-by":"crossref","first-page":"L1002","DOI":"10.1152\/ajplung.00383.2014","article-title":"Compartment-specific expression of collagens and their processing enzymes in intrapulmonary arteries of IPAH patients","volume":"308","author":"Hoffmann","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021100415901400_bib11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1164\/rccm.201409-1742OC","article-title":"Serum endostatin is a genetically determined predictor of survival in pulmonary arterial hypertension","volume":"191","author":"Damico","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021100415901400_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S1097-2765(04)00102-9","article-title":"Endostatin\u2019s antiangiogenic signaling network","volume":"13","author":"Abdollahi","year":"2004","journal-title":"Mol Cell"},{"key":"2026021100415901400_bib13","first-page":"5410","article-title":"Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase","volume":"60","author":"Kim","year":"2000","journal-title":"Cancer Res"},{"key":"2026021100415901400_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bbrc.1999.1342","article-title":"Inhibitory effect of full-length human endostatin on in vitro angiogenesis","volume":"263","author":"Taddei","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"2026021100415901400_bib15","doi-asserted-by":"crossref","first-page":"11721","DOI":"10.1074\/jbc.274.17.11721","article-title":"Endostatin induces endothelial cell apoptosis","volume":"274","author":"Dhanabal","year":"1999","journal-title":"J Biol Chem"},{"key":"2026021100415901400_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O\u2019Reilly","year":"1997","journal-title":"Cell"},{"key":"2026021100415901400_bib17","first-page":"A2244","article-title":"Endostatin suppresses the inhibitors of DNA binding\/differentiation transcription factors (ID1) and promotes pulmonary artery endothelial cell death [abstract]","volume":"195","author":"Goyanes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021100415901400_bib18","first-page":"A2885","article-title":"Endostatin-ID1-thrombospondin-1 signaling alters endothelial cell survival and is associated with poor clinical outcomes in pulmonary arterial hypertension [abstract]","volume":"197","author":"Goyanes","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021100415901400_bib19","first-page":"5580","article-title":"Endostatin associates with integrin \u03b15\u03b21 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells","volume":"62","author":"Wickstr\u00f6m","year":"2002","journal-title":"Cancer Res"},{"key":"2026021100415901400_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1165\/rcmb.2007-0248OC","article-title":"Macrophage migration inhibitory factor governs endothelial cell sensitivity to LPS-induced apoptosis","volume":"39","author":"Damico","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021100415901400_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1165\/rcmb.2009-0379OC","article-title":"p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor","volume":"44","author":"Damico","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026021100415901400_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12931-016-0412-x","article-title":"The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension","volume":"17","author":"Kaiser","year":"2016","journal-title":"Respir Res"},{"key":"2026021100415901400_bib23","doi-asserted-by":"crossref","first-page":"15494","DOI":"10.1038\/ncomms15494","article-title":"TGF-\u03b2 activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension","volume":"8","author":"Kumar","year":"2017","journal-title":"Nat Commun"},{"key":"2026021100415901400_bib24","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1038\/sj.emboj.7601400","article-title":"ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2","volume":"25","author":"Lee","year":"2006","journal-title":"EMBO J"},{"key":"2026021100415901400_bib25","doi-asserted-by":"crossref","first-page":"296069","DOI":"10.1155\/2011\/296069","article-title":"Thrombospondin-1: multiple paths to inflammation","volume":"2011","author":"Lopez-Dee","year":"2011","journal-title":"Mediators Inflamm"},{"key":"2026021100415901400_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.thromres.2009.04.005","article-title":"Elevated platelet angiostatin and circulating endothelial microfragments in idiopathic pulmonary arterial hypertension: a preliminary study","volume":"125","author":"Jurasz","year":"2010","journal-title":"Thromb Res"},{"key":"2026021100415901400_bib27","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cvr\/cvu215","article-title":"Id proteins in the vasculature: from molecular biology to cardiopulmonary medicine","volume":"104","author":"Yang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"2026021100415901400_bib28","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/cr.2008.321","article-title":"Smad3 mediates immediate early induction of Id1 by TGF-\u03b2","volume":"19","author":"Liang","year":"2009","journal-title":"Cell Res"},{"key":"2026021100415901400_bib29","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1096\/fasebj.13.15.2257","article-title":"Degradation of Id proteins by the ubiquitin-proteasome pathway","volume":"13","author":"Bounpheng","year":"1999","journal-title":"FASEB J"},{"key":"2026021100415901400_bib30","doi-asserted-by":"crossref","first-page":"32614","DOI":"10.1074\/jbc.M403794200","article-title":"Ubiquitin-proteasome-mediated degradation of Id1 is modulated by MyoD","volume":"279","author":"Trausch-Azar","year":"2004","journal-title":"J Biol Chem"},{"key":"2026021100415901400_bib31","doi-asserted-by":"crossref","first-page":"22029","DOI":"10.1074\/jbc.M109.002840","article-title":"Molecular interplay between endostatin, integrins, and heparan sulfate","volume":"284","author":"Faye","year":"2009","journal-title":"J Biol Chem"},{"key":"2026021100415901400_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1006\/mthe.2002.0590","article-title":"Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis","volume":"5","author":"Yin","year":"2002","journal-title":"Mol Ther"},{"key":"2026021100415901400_bib33","first-page":"1944","article-title":"Endostatin regulates endothelial cell adhesion and cytoskeletal organization","volume":"62","author":"Dixelius","year":"2002","journal-title":"Cancer Res"},{"key":"2026021100415901400_bib34","doi-asserted-by":"crossref","first-page":"13141","DOI":"10.1073\/pnas.0502977102","article-title":"Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner","volume":"102","author":"Isenberg","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021100415901400_bib35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jim\u00e9nez","year":"2000","journal-title":"Nat Med"},{"key":"2026021100415901400_bib36","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1083\/jcb.138.3.707","article-title":"CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells","volume":"138","author":"Dawson","year":"1997","journal-title":"J Cell Biol"},{"key":"2026021100415901400_bib37","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1023\/A:1020634924760","article-title":"Mechanosensitive induction of apoptosis in fibroblasts is regulated by thrombospondin-1 and integrin associated protein (CD47)","volume":"7","author":"Graf","year":"2002","journal-title":"Apoptosis"},{"key":"2026021100415901400_bib38","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/cvr\/cvw218","article-title":"TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction","volume":"113","author":"Rogers","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2026021100415901400_bib39","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cvr\/cvr356","article-title":"Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1","volume":"93","author":"Bauer","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2026021100415901400_bib40","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"J Clin Invest"},{"key":"2026021100415901400_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1161\/01.CIR.102.1.82","article-title":"Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured aortic smooth muscle cells","volume":"102","author":"Ricciarelli","year":"2000","journal-title":"Circulation"},{"key":"2026021100415901400_bib42","doi-asserted-by":"crossref","first-page":"14991","DOI":"10.1074\/jbc.M110.179663","article-title":"Heparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1","volume":"286","author":"Kaur","year":"2011","journal-title":"J Biol Chem"},{"key":"2026021100415901400_bib43","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.ATV.17.10.2107","article-title":"Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells","volume":"17","author":"Patel","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026021100415901400_bib44","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1535-6108(03)00141-7","article-title":"Id proteins in cell growth and tumorigenesis","volume":"3","author":"Sikder","year":"2003","journal-title":"Cancer Cell"},{"key":"2026021100415901400_bib45","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/01.CIR.0000033830.36431.46","article-title":"Stimulation of Id1 expression by bone morphogenetic protein is sufficient and necessary for bone morphogenetic protein-induced activation of endothelial cells","volume":"106","author":"Valdimarsdottir","year":"2002","journal-title":"Circulation"},{"key":"2026021100415901400_bib46","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/CIRCRESAHA.108.173567","article-title":"Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension","volume":"102","author":"Yang","year":"2008","journal-title":"Circ Res"},{"key":"2026021100415901400_bib47","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","article-title":"Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGF\u03b2\/ALK5 signaling","volume":"12","author":"Goumans","year":"2003","journal-title":"Mol Cell"},{"key":"2026021100415901400_bib48","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1164\/rccm.201606-1200OC","article-title":"Induced pluripotent stem cell model of pulmonary arterial hypertension reveals novel gene expression and patient specificity","volume":"195","author":"Sa","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021100415901400_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nm.3877","article-title":"Selective enhancement of endothelial BMPR-II with BMP9 reverses pulmonary arterial hypertension","volume":"21","author":"Long","year":"2015","journal-title":"Nat Med"},{"key":"2026021100415901400_bib50","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1172\/JCI65592","article-title":"FK506 activates BMPR2, rescues endothelial dysfunction, and reverses pulmonary hypertension","volume":"123","author":"Spiekerkoetter","year":"2013","journal-title":"J Clin Invest"},{"key":"2026021100415901400_bib51","doi-asserted-by":"crossref","first-page":"e100261","DOI":"10.1371\/journal.pone.0100261","article-title":"Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension","volume":"9","author":"Pousada","year":"2014","journal-title":"PLoS One"},{"key":"2026021100415901400_bib52","doi-asserted-by":"crossref","first-page":"1801899","DOI":"10.1183\/13993003.01899-2018","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"53","author":"Morrell","year":"2019","journal-title":"Eur Respir J"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/62\/4\/524\/66763767\/ajrcmb_62_4_524.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/62\/4\/524\/66763767\/ajrcmb_62_4_524.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:42:16Z","timestamp":1770788536000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/62\/4\/524\/8461361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":52,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,1]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2019-0056oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4]]},"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"2019-02-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-01-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}